Cholesteryl ester transfer protein inhibition: a dysfunctional endothelium

J Cardiovasc Pharmacol. 2010 May;55(5):456-8. doi: 10.1097/FJC.0b013e3181dc61d4.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Animals
  • Anticholesteremic Agents / administration & dosage
  • Anticholesteremic Agents / adverse effects*
  • Anticholesteremic Agents / therapeutic use
  • Cell Line
  • Cholesterol Ester Transfer Proteins / antagonists & inhibitors*
  • Endothelium, Vascular / drug effects*
  • Humans
  • Quinolines / administration & dosage
  • Quinolines / adverse effects*
  • Quinolines / therapeutic use

Substances

  • Anticholesteremic Agents
  • Cholesterol Ester Transfer Proteins
  • Quinolines
  • torcetrapib